Clinical outcomes in 10 patients after basilar artery stenting for symptomatic athero-occlusive disease
| Patient No. | Follow-Up (months) | mRS | Persistent Symptoms | Clinically Significant Interval Events | Maintenance Medical Therapy at Last Follow-Up |
|---|---|---|---|---|---|
| 1 | 44 | 0 | Clopidogrel, aspirin, atorvastatin | ||
| 2 | 46 | 0 | 4 hospitalizations for gastrointestinal hemorrhage secondary to excessive anticoagulation | Warfarin, aspirin | |
| 3 | 45 | 3 | Chronic imbalance, positional dizzy spells, dominant hand disability related to access site complication | MRI 44 months poststent performed to assess recurrent vertigo, diplopia, and gait ataxia while on clopidogrel showed no new infarcts. Angiogram showed 50% concentric stenosis just proximal to stent. Symptoms stabilized on heparin and remained stable on warfarin. | Warfarin, clopidogrel, simvastatin |
| 4 | 39 | 2 | Fixed difficulties with fine motor control | Warfarin, aspirin, simvastatin | |
| 5 | 10 days | 6 | NA | NA | NA |
| 6 | 29 | 3 | Fixed gait ataxia, vertigo, dysarthria, dysphagia | Aspirin, warfarin, simvastatin | |
| 7 | 38 | 3 | Fixed left hemiparesis, diplopia | Warfarin | |
| 8 | 18 | 3 | Fixed left hemiparesis, dysphagia | Major myocardial infarction 30 days after discharge from stent hospitalization. Treated by coronary artery bypass grafting surgery and automated implantable cardiac defibrillator | Warfarin, lovastatin |
| 9 | 12 | 0 | Clopidogrel, aspirin, simvastatin | ||
| 10 | 8 | 2 | Fixed gait ataxia, dysarthria, dysphagia | Aspirin, fenofibrate |
Note:—mRS indicates modified Rankin score; MRI, magnetic resonance imaging, NA, not applicable.